STANDART TREATMENT AND MODERN APPROACHES TO COMMUNITY-ACQUIRED PNEUMONIA IN INFANTS
DOI:
https://doi.org/10.55640/Keywords:
community-acquired pneumonia, infants, antibiotic therapy, respiratory support, clinical guidelines, pediatrics.Abstract
Community-acquired pneumonia (CAP) in infants remains one of the leading causes of morbidity and hospitalization in pediatric practice. The immaturity of the immune system, anatomical and physiological characteristics of the respiratory tract, and high susceptibility to infections contribute to the severe course of the disease in this age group. Modern approaches to CAP management are based on early diagnosis, rational antibiotic therapy, supportive care, and preventive strategies. This article reviews standard treatment protocols and current clinical recommendations for the management of community-acquired pneumonia in infants.
Downloads
References
1.World Health Organization. Revised WHO classification and treatment of childhood pneumonia.
2.McIntosh K. Community-acquired pneumonia in children. New England Journal of Medicine.
3.Bradley J.S., et al. The management of community-acquired pneumonia in infants and children. Clinical Infectious Diseases.
4.Russian Clinical Guidelines. Community-acquired pneumonia in children.
5.Jain S., et al. Community-acquired pneumonia requiring hospitalization among U.S. children. New England Journal of Medicine.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India